Descriptions
Autoinhibitory domains (AIDs)
Target domain |
26-218 (CARD domains) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q53B87
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q53B87-F1 | Predicted | AlphaFoldDB |
No variants for Q53B87
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q53B87 |
No associated diseases with Q53B87
8 regional properties for Q53B87
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | CARD domain | 26 - 120 | IPR001315-1 |
domain | CARD domain | 134 - 218 | IPR001315-2 |
repeat | Leucine-rich repeat | 898 - 920 | IPR001611-1 |
repeat | Leucine-rich repeat | 927 - 948 | IPR001611-2 |
repeat | Leucine-rich repeat | 981 - 1005 | IPR001611-3 |
domain | NACHT nucleoside triphosphatase | 293 - 462 | IPR007111 |
domain | NOD2, winged helix domain | 546 - 587 | IPR041075 |
domain | NACHT, LRR and PYD domains-containing protein, helical domain HD2 | 603 - 757 | IPR041267 |
Functions
5 GO annotations of cellular component
Name | Definition |
---|---|
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
1 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
7 GO annotations of biological process
Name | Definition |
---|---|
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
cellular response to muramyl dipeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
nucleotide-binding oligomerization domain containing 2 signaling pathway | The series of molecular signals initiated by the binding of a ligand (such as a bacterial peptidoglycan) to a cytoplasmic nucleotide-binding oligomerization domain containing 2 (NOD2) protein receptor, and ending with regulation of a downstream cellular process. |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
3 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q6E804 | NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 | Bos taurus (Bovine) | SS |
Q9HC29 | NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (Human) | EV |
Q8K3Z0 | Nod2 | Nucleotide-binding oligomerization domain-containing protein 2 | Mus musculus (Mouse) | EV |
10 | 20 | 30 | 40 | 50 | 60 |
MGEEGGSVSH | DEEERASVLL | GHSLGCEMCS | QEAFQAQRSQ | LVELLVSGSL | EGFESVLDWL |
70 | 80 | 90 | 100 | 110 | 120 |
LSWEVLSWED | YEGFHLLGQP | LSHLARRLLD | TVWNKGTWAC | QKLIAAAQEA | QADSQSPKLH |
130 | 140 | 150 | 160 | 170 | 180 |
GCWDPHSLHP | ARDLQSHRPA | IVRRLHNHVE | NMLDLAWERG | FVSQYECDEI | RLPIFTPSQR |
190 | 200 | 210 | 220 | 230 | 240 |
ARRLLDLATV | KANGLAAFLL | QHVQELPVPL | ALPLEAATCK | KYMAKLRTTV | SAQSRFLSTY |
250 | 260 | 270 | 280 | 290 | 300 |
DGAETLCLED | IYTENVLEVW | ADVGMAGPPQ | KSPATLGLEE | LFSTPGHLND | DADTVLVVGE |
310 | 320 | 330 | 340 | 350 | 360 |
AGSGKSTLLQ | RLHLLWAAGR | DFQEFLFVFP | FSCRQLQCMA | KPLSVRTLLF | EHCCWPDVGQ |
370 | 380 | 390 | 400 | 410 | 420 |
EDIFQLLLDH | PDRVLLTFDG | FDEFKFRFTD | RERHCSPTDP | TSVQTLLFNL | LQGNLLKNAR |
430 | 440 | 450 | 460 | 470 | 480 |
KVVTSRPAAV | SAFLRKYIRT | EFNLKGFSEQ | GIELYLRKRH | REPGVADRLI | RLLQATSALH |
490 | 500 | 510 | 520 | 530 | 540 |
GLCHLPVFSW | MVSKCHQELL | LQEGGSPKTT | TDMYLLILQH | FLLHATPPDS | ASQGLGPSLL |
550 | 560 | 570 | 580 | 590 | 600 |
RGRLPTLLHL | GRLALWGLGM | CCYVFSAQQL | QAAQVSPDDI | SLGFLVRAKG | VVPGSTAPLE |
610 | 620 | 630 | 640 | 650 | 660 |
FLHITFQCFF | AAFYLALSAD | VPPALLRHLF | NCGRPGNSPM | ARLLPTMCIQ | GSEGKDSSVA |
670 | 680 | 690 | 700 | 710 | 720 |
ALLQKAEPHN | LQITAAFLAG | LLSREHWGLL | AECQTSEKAL | LRRQACARWC | LARSLRKHFH |
730 | 740 | 750 | 760 | 770 | 780 |
SIPPAAPGEA | KSVHAMPGFI | WLIRSLYEMQ | EERLARKAAR | GLNVGHLKLT | FCSVGPAECA |
790 | 800 | 810 | 820 | 830 | 840 |
ALAFVLQHLR | RPVALQLDYN | SVGDIGVEQL | LPCLGVCKAL | YLRDNNISDR | GICKLIECAL |
850 | 860 | 870 | 880 | 890 | 900 |
HCEQLQKLAL | FNNKLTDGCA | HSMAKLLACR | QNFLALRLGN | NYITAAGAQV | LAQGLRGNTS |
910 | 920 | 930 | 940 | 950 | 960 |
LQFLGFWGNR | VGDEGAQALA | EALGDHQSLR | WLSLVGNNIG | SVGAQALALM | LAKNVMLEEL |
970 | 980 | 990 | 1000 | 1010 | 1020 |
CLEENHLQDE | GVCSLAEGLK | KNSSLKILKL | SNNCITYLGA | EALLQALERN | DTILEVWLRG |
1030 | |||||
NTFSLEEVDK | LGCRDTRLLL |